Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT01200758
Status:
COMPLETED
Last Update Posted:
2018-11-27
First Post:
2010-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2012-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-10
First Submit QC Date:
None
Study First Post Date:
2010-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-07
Results First Submit QC Date:
None
Results First Post Date:
2015-08-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-29
Last Update Post Date:
2018-11-27
Last Update Post Date Type:
ACTUAL